85-1587-32 BMP8A, Recombinant, Human, (BMP-8A, Bone Morphogenetic Protein 8A) 25ug B2553-35M

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • MP-8, also known as osteogenic protein 2 (OP-2), was first isolated from a hippocampal library in a screen to identify relatives of BMP-7/OP-1. BMPs are a family of structurally and functionally related proteins and represent a subfamily of the transforming growth factor b (TGF-b) superfamily. BMPs are involved in a wide range of processes including embryogenesis, tissue morphogenesis, cell differentiation and migration, and tumorigenesis. Cellular responses to BMPs are mediated by hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. BMP-8a and BMP-8b, produced from separate genes, share 98% aa sequence identity in human but only 74% in mouse within the mature regions. Human BMP-8a is synthesized as a 402aa precursor protein that is cleaved between aa263 and aa264 to release the C-terminal mature protein. Mature human BMP-8a shares 90% and 68% aa sequence identity with mouse mature BMP-8a and -8b, respectively. BMP-8a is expressed during pregnancy in the deciduum and trophoblast cells, by inner root sheath cells of developing hair follicles, and by the epididymis and spermatids. In the mouse it cooperates with BMP-7 in the maintenance of spermatogenesis but is not required for the initiation of spermatogenesis. BMP-8b, in contrast, is required for both the initiation and maintenance of spermatogenesis. BMP-8a is induced during osteoblast differentiation at the onset of mineralization and during the osteogenic phase of bone repair in osteoblasts and osteocytes. BMP-8a/b is also highly expressed in osteosarcomas.
  • Source:Recombinant corresponding to aa264-402 from human BMP-8a expressed in CHO cell line.
  • Molecular Weight:~15.7kD
  • Biological Activity:Measured by its ability to inhibit the cell growth of DU145 human prostate carcinoma cells. The ED50 for this effect is typically 0.2-1ug/ml.
  • Endotoxin: ~1EU/1ug (LAL)
  • Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile buffer. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 3 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

  • Size:25ug
  • Source Antigen:Recombinant, CHO cells
  • Grade:Highly Purified
  • Purity:~95% (SDS-PAGE)
  • Form:Supplied as a lyophilized powder in hydrochloride. BSA free. Reconstitute with 4mM hydrochloride to 0.25mg/ml.
  • Molecular Weight Non Ab:15.7
  • EU Commodity Code:30021019
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-1587-32
型番
B2553-35M
入り数
1個
標準価格
264,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る